Literature DB >> 35951448

Characterization of Risk Factors Among Individuals with a History of Incarceration Presenting to a Sexually Transmitted Infections Clinic: Implications for HIV and STI Prevention and Care.

Matthew J Murphy1,2,3, Brooke G Rogers2,4,5, Laura C Chambers1,5, Alexandra Zanowick-Marr5, Drew Galipeau5, Madeline Noh1, Ty Scott1, Siena C Napoleon1,5, Jennifer Rose6, Philip A Chan1,2,5.   

Abstract

More than 2 million people are incarcerated in the United States with many millions more processed through correctional facilities annually. Communities impacted by incarceration are also disproportionately impacted by the HIV and sexually transmitted infection (STI) epidemics. However, relatively little is known about the behaviors that place individuals with a history of incarceration at risk for HIV/STI acquisition. We utilized clinical data from patients presenting to an STI clinic located in Providence, Rhode Island. A latent class analysis was conducted on reported HIV acquisition risk behavior and STI testing results on a total of 1129 encounters where a history of incarceration was reported. A total of three classes were identified. Class 1 (N = 187, 11%), more frequently reported 10+ sexual partners (45%), an STI diagnosis (48%) and sex while intoxicated (86%) in the past year as well as identifying as a man who has sex with other men (60%). Class 2 (N = 57, 5%) was more likely to report giving (53%) and receiving (44%) money/drugs for sex in the past year as well as a history of injecting drugs (61%) and using methamphetamine (60%). Class 3 (N = 885, 78%) most frequently reported 0-2 sexual partners (48%), identified as Black (27%), Hispanic/Latino (69%) and a man who only has sex with women (80%). Class 1 had significantly higher odds ratio (1.8, 95% confidence interval = 1.3-2.5) of testing HIV/STI positive. The results provide important insights into risk subgroups for those with a history of incarceration at risk of HIV/STI acquisition.

Entities:  

Keywords:  HIV/STI risk; PrEP implementation; incarceration; latent class analysis

Mesh:

Year:  2022        PMID: 35951448      PMCID: PMC9419926          DOI: 10.1089/apc.2022.0083

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.944


  54 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 2.  Global epidemiology of HIV among female sex workers: influence of structural determinants.

Authors:  Kate Shannon; Steffanie A Strathdee; Shira M Goldenberg; Putu Duff; Peninah Mwangi; Maia Rusakova; Sushena Reza-Paul; Joseph Lau; Kathleen Deering; Michael R Pickles; Marie-Claude Boily
Journal:  Lancet       Date:  2014-07-22       Impact factor: 79.321

3.  "You're in a world of chaos": experiences accessing HIV care and adhering to medications after incarceration.

Authors:  Alexis C Dennis; Clare Barrington; Sayaka Hino; Michele Gould; David Wohl; Carol E Golin
Journal:  J Assoc Nurses AIDS Care       Date:  2015-06-14       Impact factor: 1.354

4.  Correlates of retention in HIV care after release from jail: results from a multi-site study.

Authors:  Amy L Althoff; Alexei Zelenev; Jaimie P Meyer; Jeannia Fu; Shan-Estelle Brown; Panagiotis Vagenas; Ann K Avery; Jacqueline Cruzado-Quiñones; Anne C Spaulding; Frederick L Altice
Journal:  AIDS Behav       Date:  2013-10

5.  The REDCap consortium: Building an international community of software platform partners.

Authors:  Paul A Harris; Robert Taylor; Brenda L Minor; Veida Elliott; Michelle Fernandez; Lindsay O'Neal; Laura McLeod; Giovanni Delacqua; Francesco Delacqua; Jacqueline Kirby; Stephany N Duda
Journal:  J Biomed Inform       Date:  2019-05-09       Impact factor: 6.317

6.  California's Prisoner Protections for Family and Community Health Act : Implementing a Mandated Condom Access Program in State Prisons, 2015-2016.

Authors:  Kimberley D Lucas; Joseph Bick; Janet C Mohle-Boetani
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

7.  Predictors of drug use in prison among incarcerated Black men.

Authors:  Tawandra L Rowell; Elwin Wu; Carl L Hart; Rahwa Haile; Nabila El-Bassel
Journal:  Am J Drug Alcohol Abuse       Date:  2012-07-02       Impact factor: 3.829

8.  Estimating the number of persons who inject drugs in the united states by meta-analysis to calculate national rates of HIV and hepatitis C virus infections.

Authors:  Amy Lansky; Teresa Finlayson; Christopher Johnson; Deborah Holtzman; Cyprian Wejnert; Andrew Mitsch; Deborah Gust; Robert Chen; Yuko Mizuno; Nicole Crepaz
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

9.  Knowledge, interest, and anticipated barriers of pre-exposure prophylaxis uptake and adherence among gay, bisexual, and men who have sex with men who are incarcerated.

Authors:  Lauren Brinkley-Rubinstein; Meghan Peterson; Trisha Arnold; Amy S Nunn; Curt G Beckwith; Breana Castonguay; Eric Junious; Chantal Lewis; Philip A Chan
Journal:  PLoS One       Date:  2018-12-07       Impact factor: 3.240

10.  Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.

Authors:  Jack Stone; Hannah Fraser; Aaron G Lim; Josephine G Walker; Zoe Ward; Louis MacGregor; Adam Trickey; Sam Abbott; Steffanie A Strathdee; Daniela Abramovitz; Lisa Maher; Jenny Iversen; Julie Bruneau; Geng Zang; Richard S Garfein; Yung-Fen Yen; Tasnim Azim; Shruti H Mehta; Michael-John Milloy; Margaret E Hellard; Rachel Sacks-Davis; Paul M Dietze; Campbell Aitken; Malvina Aladashvili; Tengiz Tsertsvadze; Viktor Mravčík; Michel Alary; Elise Roy; Pavlo Smyrnov; Yana Sazonova; April M Young; Jennifer R Havens; Vivian D Hope; Monica Desai; Ellen Heinsbroek; Sharon J Hutchinson; Norah E Palmateer; Andrew McAuley; Lucy Platt; Natasha K Martin; Frederick L Altice; Matthew Hickman; Peter Vickerman
Journal:  Lancet Infect Dis       Date:  2018-10-29       Impact factor: 71.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.